The activation of GLP-1 receptors (GLP-1R) plays protective roles against multiple neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease, as well as diabetes mellitus and ischemia (Grieco et al., 2019). Here, GLP1R is linked to early-onset autosomal dominant Alzheimer disease.